Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 23, 2020
Assessment of left and right ventricular functional parameters using dynamic dual-tracer [<sup>13</sup>N]NH3 and [<sup>18</sup>F]FDG PET/MRISazan Rasul, Dietrich Beitzke, Tim Wollenweber, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 11, 2022
Does [99mTc]-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) soft tissue uptake allow the identification of patients with the diagnosis of cardiac transthyretin-related (ATTR) amyloidosis with higher risk for polyneuropathy?Tim Wollenweber, Elisabeth Kretschmer-Chott, Raphael Wurm, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 21, 2019
[<sup>68</sup>Ga]Pentixafor PET/MR imaging of chemokine receptor 4 expression in the human carotid arteryXiang Li, Wei Yu, Tim Wollenweber, et al.European Journal of Nuclear Medicine and Molecular Imaging|November 25, 2024
Clinical significance of quantitative assessment of right ventricular amyloid burden with [<sup>99m</sup>Tc]Tc-DPD SPECT/CT in transthyretin cardiac amyloidosisMin Zhao, Raffaella Calabretta, Patrick Binder, et al.European Journal of Nuclear Medicine and Molecular Imaging|October 31, 2020
Prediction of response and survival after standardized treatment with 7400 MBq <sup>177</sup>Lu-PSMA-617 every 4 weeks in patients with metastatic castration-resistant prostate cancerSazan Rasul, Markus Hartenbach, Tim Wollenweber, et al.Cancers|June 2, 2021
Response and Toxicity to the Second Course of 3 Cycles of <sup>177</sup>Lu-PSMA Therapy Every 4 Weeks in Patients with Metastatic Castration-Resistant Prostate CancerSazan Rasul, Tim Wollenweber, Lucia Zisser, et al.Nuclear Medicine Communications|September 19, 2022
Response to [ 177 Lu]Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer patients presenting with only lymph node metastasesLucia Zisser, Josef Yu, André Oszwald, et al.Pharmaceuticals (Basel, Switzerland)|January 17, 2019
Optimization of the Automated Synthesis of [11C]mHED-Administered and Apparent Molar ActivitiesChrysoula Vraka, Verena Pichler, Neydher Berroterán-Infante, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|April 30, 2026
Active Brown Adipose Tissue Is Associated With Reduced Arterial Inflammation and Less Atherogenic Circulating Factors in Individuals With ObesityOana C Kulterer, Carsten T Herz, Dietmar Pils, et al.Current Oncology (Toronto, Ont.)|September 30, 2021
Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate CancerTim Wollenweber, Lucia Zisser, Elisabeth Kretschmer-Chott, et al.Pageof 3